Designation of New Animal Drugs for Minor Uses or Minor Species; Reopening of the Comment Period, 76732 [05-24512]
Download as PDF
76732
Federal Register / Vol. 70, No. 248 / Wednesday, December 28, 2005 / Proposed Rules
175°00′00″ W.; to lat. 59°59′57″ N., long.
168°00′08″ W.; to lat. 57°45′57″ N., long.
161°46′08″ W.; to the point of beginning.
*
*
*
*
2). Interested persons were originally
given until December 12, 2005, to
comment.
*
Issued in Washington, DC, on December
21, 2005.
Edith V. Parish,
Manager, Airspace and Rules.
[FR Doc. E5–7987 Filed 12–27–05; 8:45 am]
BILLING CODE 4910–13–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
21 CFR Parts 20, 510, 514, and 516
[Docket No. 2005N–0329]
RIN 0910–AF60
Designation of New Animal Drugs for
Minor Uses or Minor Species;
Reopening of the Comment Period
AGENCY:
Food and Drug Administration,
HHS.
Proposed rule; reopening of the
comment period.
ACTION:
sroberts on PROD1PC70 with PROPOSALS
SUMMARY: The Food and Drug
Administration (FDA) is reopening until
January 27, 2006, the comment period
for the proposed rule published in the
Federal Register of September 27, 2005
(70 FR 56394), proposing implementing
regulations for designation of new
animal drugs for minor uses and minor
species under section 573 of the Federal
Food, Drug, and Cosmetic Act (the act).
FDA is reopening the comment period
to update comments and to receive any
new information.
DATES: Submit written or electronic
comments by January 27, 2006.
ADDRESSES: Submit written comments
to the Division of Dockets Management
(HFA–305), Food and Drug
Administration, 5630 Fishers Lane, rm.
1061, Rockville, MD 20852. Submit
electronic comments to https://
www.fda.gov/dockets/ecomments.
FOR FURTHER INFORMATION CONTACT:
Andrew Beaulieu, Center for Veterinary
Medicine (HFV–50), Food and Drug
Administration, 7519 Standish Pl.,
Rockville, MD 20855, 240–276–9090, email: Andrew.Beaulieu@fda.gov.
SUPPLEMENTARY INFORMATION:
I. Background
In the Federal Register of September
27, 2005 (70 FR 56394), FDA proposed
implementing regulations for
designation of new animal drugs for
minor uses and minor species under
section 573 of the act (21 U.S.C. 360ccc–
VerDate Aug<31>2005
16:13 Dec 27, 2005
Jkt 208001
II. Request for Comments
Following publication of the
September 27, 2005, proposed rule, FDA
received requests to allow interested
persons additional time to comment.
The requesters asserted that the time
period of 75 days was insufficient to
respond fully to FDA’s specific requests
for comments and to allow potential
respondents to thoroughly evaluate and
address pertinent issues.
III. How to Submit Comments
Interested persons may submit to the
Division of Dockets Management (see
ADDRESSES) written or electronic
comments regarding this document.
Submit a single copy of electronic
comments to https://www.fda.gov/
dockets/ecomments or two paper copies
of any mailed comments, except that
individuals may submit one paper copy.
Comments are to be identified with the
docket number found in brackets in the
heading of this document. Received
comments may be seen in the Division
of Dockets Management between 9 a.m.
and 4 p.m., Monday through Friday.
Dated: December 21, 2005.
Jeffrey Shuren,
Assistant Commissioner for Policy.
[FR Doc. 05–24512 Filed 12–27–05; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF THE TREASURY
Internal Revenue Service
26 CFR Part 1
[REG–143244–05]
RIN 1545–BE93
Guidance Under Section 7874 for
Determining Ownership by Former
Shareholders or Partners of Domestic
Entities
Internal Revenue Service (IRS),
Treasury.
ACTION: Notice of proposed rulemaking
by cross-reference to temporary
regulations and notice of public hearing.
AGENCY:
SUMMARY: In the Rules and Regulations
section of this issue of the Federal
Register, the IRS is issuing temporary
regulations relating to the disregard of
affiliate-owned stock in determining the
percentage of stock of a foreign
corporation held by former shareholders
or partners of a domestic entity, in order
to determine whether the foreign
corporation is a surrogate foreign
PO 00000
Frm 00015
Fmt 4702
Sfmt 4702
corporation under section 7874 of the
Internal Revenue Code (Code). The text
of those regulations also serves as the
text of these proposed regulations. This
document also provides notice of a
public hearing on these proposed
regulations.
DATES: Written or electronic comments
must be received by March 28, 2006.
Outlines of topics to be discussed at the
public hearing scheduled for April 27,
2006, at 10 a.m., must be received by
April 6, 2006.
ADDRESSES: Send submissions to:
CC:PA:LPD:PR (REG–143244–05), room
5203, Internal Revenue Service, P.O.
Box 7604, Ben Franklin Station,
Washington, DC 20044. Submissions
may be hand-delivered Monday through
Friday between the hours of 8 a.m. and
4 p.m. to: CC:PA:LPD:PR (REG–143244–
05), Courier’s Desk, Internal Revenue
Service, 1111 Constitution Avenue,
NW., Washington, DC, or sent
electronically, via the IRS Internet site
at: www.irs.gov/regs or via the Federal
eRulemaking Portal at
www.regulations.gov (IRS–REG–
143244–05).
FOR FURTHER INFORMATION CONTACT:
Concerning the proposed regulations,
Jefferson VanderWolk at (202) 622–
3810; concerning submission and
delivery of comments and the public
hearing, Robin Jones at (202) 622–7180
(not toll-free numbers).
SUPPLEMENTARY INFORMATION:
Background and Explanation of
Provisions
Temporary regulations in the Rules
and Regulations section of this issue of
the Federal Register amend the Income
Tax Regulations (26 CFR part 1) relating
to section 7874. The temporary
regulations set forth rules on
disregarding affiliate-owned stock in
determining the percentage of stock of a
foreign corporation held by former
shareholders or partners of a domestic
entity by reason of holding stock or a
partnership interest in the domestic
entity, for purposes of determining
whether the foreign corporation is a
surrogate foreign corporation under
section 7874(a)(2)(B). The text of those
regulations also serves as the text of
these proposed regulations. The
preamble to the temporary regulations
explains the amendments.
Special Analyses
It has been determined that this notice
of proposed rulemaking is not a
significant regulatory action as defined
in Executive Order 12866. Therefore, a
regulatory assessment is not required. It
has also been determined that section
E:\FR\FM\28DEP1.SGM
28DEP1
Agencies
[Federal Register Volume 70, Number 248 (Wednesday, December 28, 2005)]
[Proposed Rules]
[Page 76732]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-24512]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
21 CFR Parts 20, 510, 514, and 516
[Docket No. 2005N-0329]
RIN 0910-AF60
Designation of New Animal Drugs for Minor Uses or Minor Species;
Reopening of the Comment Period
AGENCY: Food and Drug Administration, HHS.
ACTION: Proposed rule; reopening of the comment period.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is reopening until
January 27, 2006, the comment period for the proposed rule published in
the Federal Register of September 27, 2005 (70 FR 56394), proposing
implementing regulations for designation of new animal drugs for minor
uses and minor species under section 573 of the Federal Food, Drug, and
Cosmetic Act (the act). FDA is reopening the comment period to update
comments and to receive any new information.
DATES: Submit written or electronic comments by January 27, 2006.
ADDRESSES: Submit written comments to the Division of Dockets
Management (HFA-305), Food and Drug Administration, 5630 Fishers Lane,
rm. 1061, Rockville, MD 20852. Submit electronic comments to https://
www.fda.gov/dockets/ecomments.
FOR FURTHER INFORMATION CONTACT: Andrew Beaulieu, Center for Veterinary
Medicine (HFV-50), Food and Drug Administration, 7519 Standish Pl.,
Rockville, MD 20855, 240-276-9090, e-mail: Andrew.Beaulieu@fda.gov.
SUPPLEMENTARY INFORMATION:
I. Background
In the Federal Register of September 27, 2005 (70 FR 56394), FDA
proposed implementing regulations for designation of new animal drugs
for minor uses and minor species under section 573 of the act (21
U.S.C. 360ccc-2). Interested persons were originally given until
December 12, 2005, to comment.
II. Request for Comments
Following publication of the September 27, 2005, proposed rule, FDA
received requests to allow interested persons additional time to
comment. The requesters asserted that the time period of 75 days was
insufficient to respond fully to FDA's specific requests for comments
and to allow potential respondents to thoroughly evaluate and address
pertinent issues.
III. How to Submit Comments
Interested persons may submit to the Division of Dockets Management
(see ADDRESSES) written or electronic comments regarding this document.
Submit a single copy of electronic comments to https://www.fda.gov/
dockets/ecomments or two paper copies of any mailed comments, except
that individuals may submit one paper copy. Comments are to be
identified with the docket number found in brackets in the heading of
this document. Received comments may be seen in the Division of Dockets
Management between 9 a.m. and 4 p.m., Monday through Friday.
Dated: December 21, 2005.
Jeffrey Shuren,
Assistant Commissioner for Policy.
[FR Doc. 05-24512 Filed 12-27-05; 8:45 am]
BILLING CODE 4160-01-S